Trending...
- New Frontier Aerospace and Air Force Institute of Technology Sign CRADA to Advance Hypersonic VTOL Aircraft
- The GENIUS Act Kicks Off a New Era of Compliance — WinnerMining Helps XRP & ETH Holders Passively Grow Their Assets
- HAR Dental Integrates X-Guide Technology for Precision Implant Surgery
NEW YORK - PrAtlas -- STS Capital Partners is pleased to announce the appointment of Ross Toohey as a Managing Director. A founder-turned-M&A strategist with a track record of building, scaling, and successfully exiting businesses, Ross brings over two decades of experience across entrepreneurship, corporate development, and strategic advisory. Having led his own company through a premium private equity exit and advised others on both buy- and sell-side transactions, Ross offers a uniquely holistic perspective that enhances STS's ability to deliver Extraordinary Exits™ for founder-led and mid-market companies.
Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America's largest independent firms. He spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.
More on PrAtlas
In 2019, Ross led the successful sale of 2e Group to medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company's growth to over $1.1 billion in enterprise value.
Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his expertise in leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value. He is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services.
Ross is a Certified Exit Planning Advisor (CEPA) and serves as Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents' Organization (YPO).
More on PrAtlas
"Ross has sat in the founder's seat, scaled a business into a market leader, and achieved a premium exit. Now, as an STS Managing Director, he draws on that firsthand experience to help our clients do the same – maximizing value and creating extraordinary outcomes," said Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.
Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America's largest independent firms. He spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.
More on PrAtlas
- Databahn Reveals Smart Sales Agent for Strategic Account Plans
- Editorial Freelancers Association and Thurgood Marshall College Fund Announce Partnership to Advance Editorial Careers for HBCU Students
- ASI Showcasing Constituent Engagement Solutions at ASAE Annual Meeting & Spotlighting iMIS® Partner Marketplace
- LIB's Walk-In Environmental Chambers: Scalable, Specialized, and Built for Industry Extremes
- Vitanergy Health US Inc. Launches Three New Women's Supplements in the US: Vegan, Clean-Label, and Made in the USA
In 2019, Ross led the successful sale of 2e Group to medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company's growth to over $1.1 billion in enterprise value.
Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his expertise in leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value. He is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services.
Ross is a Certified Exit Planning Advisor (CEPA) and serves as Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents' Organization (YPO).
More on PrAtlas
- Boingo Emerges as the #1 Platform for Finding Real Estate in Mexico — Outpacing Traditional Portals
- Karapancev Law Welcomes New Associate Lawyers as Firm Expands Capacity
- eJoule Supplies Wyon Swiss Batteries High Performance Single Crystal Cathode Active Material
- Now Available for Booking, Appearances, Interviews, and Features: Atlanta Hip Hop Legend Steps Back into the Spotlight
- The Detroit Golden Jazz Fest Shuttle Returns for 2025!
"Ross has sat in the founder's seat, scaled a business into a market leader, and achieved a premium exit. Now, as an STS Managing Director, he draws on that firsthand experience to help our clients do the same – maximizing value and creating extraordinary outcomes," said Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.
Source: STS Capital Partners
0 Comments
Latest on PrAtlas
- HAR Dental Integrates X-Guide Technology for Precision Implant Surgery
- BitTitan Appoints Florent Aonon to Lead EMEA Sales Amid Continued Global Growth
- The GENIUS Act Kicks Off a New Era of Compliance — WinnerMining Helps XRP & ETH Holders Passively Grow Their Assets
- ABC Quant Launches Risk Shell AI Platform (Beta II Release Candidate)
- CCHR: Psychiatric Commitment of the Homeless is a Dangerous, Costly Failure
- Quality Homes & Luxury Lifestyle at Heritage at South Brunswick!
- New Frontier Aerospace and Air Force Institute of Technology Sign CRADA to Advance Hypersonic VTOL Aircraft
- Say Goodbye to Summer! Easing the Mental Health Transition Back to School
- $750 Million Projected Market; NRx Pharmaceuticals, Inc files Citizens Petition to FDA Seeking Removal of Benzethonium Chloride from Ketamine Products
- TUHLULA DA VIRGO – The Rise of a Star
- SolMining announces $88 million in funding
- Top Edu-Tainment IP, Badanamu, enters children's mental health space, launching Healthy Kids Music Network
- Costa Oil Partners with Rick Ware Racing for NASCAR Cup Series Debut at Iowa Speedway
- DARA Abrams NYC Stories Art Experience at One Art Space
- Buildout Unveils Rethink+: Revolutionizing Commercial Real Estate Prospecting with Seamless CRM Integration
- purelyIV Launches Niagen® IV Therapy – A Breakthrough in NAD+ Cellular Wellness
- Jewellok Unveils Cutting-Edge Specialty Gas Changeover Manifolds to Revolutionize Industrial and Medical Gas Delivery
- Press Snooze on Summer: 8 Inns Team Up to Help Guests Sleep In
- On the 30th anniversary of the Netscape IPO the inventor of the banner ad warns: "Trouble ahead."
- Early Bird Registration Now Open for the Inaugural OpenSSL Conference 2025